NPI-verified accounts for pain management practices
Precision Biologics ties every account to an NPI number rather than a general business address, which keeps ordering authority with a licensed physician and matches how most pain management and physical medicine groups already track product by lot internally.
Group practices with more than one Madison-area location can add additional receiving sites once the primary NPI and clinical contact are verified.
Madison
NPPES registry listings, primary taxonomy, retrieved 2026-10-27
131- Pain Medicine
- 80
- Physical Medicine & Rehabilitation
- 51
Documentation requested before a first order
Most pain management practices ask for the same core set of records before adding a new supplier: a certificate of analysis, a donor eligibility summary, and a lot release record. All three are available on request to verified accounts for every Wharton's jelly and exosome product we distribute.
For exosome products specifically, we can also provide the supplier's characterization data, such as nanoparticle tracking analysis and marker identification, as analytical background separate from any clinical claim.
Receiving cold-chain and shelf-stable shipments
Cryopreserved formats arrive overnight on dry ice in validated containers and should be checked against their lot number on arrival; lyophilized formats are shelf-stable and do not require the same handling. We confirm a staffed delivery window with the practice before scheduling a first shipment.
Confirming regulatory standing
Before ordering, practices typically confirm the ordering physician's license is current with the Wisconsin Medical Board and that their own counsel has reviewed how a specific product's use fits the federal framework for human cell and tissue products. Precision Biologics supports that process with documentation; the regulatory determination itself belongs to the practice.
FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.
These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.
Frequently asked questions
Does the Pain Medicine and Physical Medicine & Rehabilitation split in the NPPES data mean anything for ordering?+
No. Account setup and documentation are the same regardless of which of those taxonomies a provider is listed under; the split is only a feature of how the registry classifies specialties.
Can our practice request characterization data for an exosome product before opening an account?+
Yes. Supplier-reported characterization data, such as nanoparticle tracking analysis and marker identification, is available on request alongside the standard documentation package.
Who at Precision Biologics do we talk to about documentation questions?+
Verified accounts have access to physician-level conversations focused on documentation and logistics; these are not a substitute for clinical or legal advice.